Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [41] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
    Kanai, Masashi
    Yoshimura, Kenichi
    Tsumura, Takehiko
    Asada, Masanori
    Suzuki, Chihiro
    Niimi, Miyuki
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Nitta, Takashi
    Yasuchika, Kentaro
    Taura, Kojiro
    Mori, Yukiko
    Hamada, Akihiko
    Inoue, Naoya
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    Ikai, Iwao
    Fukushima, Masanori
    Uemoto, Shinji
    Hatano, Etsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1429 - 1434
  • [42] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Naru Kondo
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Naoya Nakagawa
    Shinya Takahashi
    Hiroki Ohge
    Taijiro Sueda
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 775 - 781
  • [43] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Nakai, Y.
    Isayama, H.
    Sasaki, T.
    Sasahira, N.
    Tsujino, T.
    Toda, N.
    Kogure, H.
    Matsubara, S.
    Ito, Y.
    Togawa, O.
    Arizumi, T.
    Hirano, K.
    Tada, M.
    Omata, M.
    Koike, K.
    BRITISH JOURNAL OF CANCER, 2012, 106 (12) : 1934 - 1939
  • [44] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Y Nakai
    H Isayama
    T Sasaki
    N Sasahira
    T Tsujino
    N Toda
    H Kogure
    S Matsubara
    Y Ito
    O Togawa
    T Arizumi
    K Hirano
    M Tada
    M Omata
    K Koike
    British Journal of Cancer, 2012, 106 : 1934 - 1939
  • [45] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Takahashi, Shinya
    Ohge, Hiroki
    Sueda, Taijiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 775 - 781
  • [46] PHASE II STUDY OF ORAL S-1 AND CONCURRENT RADIOTHERAPY IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Sudo, Kentaro
    Yamaguchi, Taketo
    Ishihara, Takeshi
    Nakamura, Kazuyoshi
    Hara, Taro
    Denda, Tadamichi
    Tawada, Katsunobu
    Imagumbai, Toshiyuki
    Araki, Hitoshi
    Sakai, Mitsuhirc
    Hatano, Kazuo
    Kawakami, Hiroyuki
    Uno, Takashi
    Ito, Hisao
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 119 - 125
  • [47] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    Ohkawa, S.
    Okusaka, T.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Hamamoto, Y.
    Nakamori, S.
    Tsuchiya, Y.
    Baba, H.
    Ishii, H.
    Omuro, Y.
    Sho, M.
    Matsumoto, S.
    Yamada, N.
    Yanagimoto, H.
    Unno, M.
    Ichikawa, Y.
    Takahashi, S.
    Watanabe, G.
    Wakabayashi, G.
    Egawa, N.
    Tsuda, M.
    Hosotani, R.
    Hamada, C.
    Hyodo, I.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1428 - 1434
  • [48] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    S Ohkawa
    T Okusaka
    H Isayama
    A Fukutomi
    K Yamaguchi
    M Ikeda
    A Funakoshi
    M Nagase
    Y Hamamoto
    S Nakamori
    Y Tsuchiya
    H Baba
    H Ishii
    Y Omuro
    M Sho
    S Matsumoto
    N Yamada
    H Yanagimoto
    M Unno
    Y Ichikawa
    S Takahashi
    G Watanabe
    G Wakabayashi
    N Egawa
    M Tsuda
    R Hosotani
    C Hamada
    I Hyodo
    British Journal of Cancer, 2015, 112 : 1428 - 1434
  • [49] A Multicenter Phase II Trial of S-1 With Concurrent Radiation Therapy for Locally Advanced Pancreatic Cancer
    Ikeda, Masafumi
    Ioka, Tatsuya
    Ito, Yoshinori
    Yonemoto, Naohiro
    Nagase, Michitaka
    Yamao, Kenji
    Miyakawa, Hiroyuki
    Ishii, Hiroshi
    Furuse, Junji
    Sato, Keiko
    Sato, Tosiya
    Okusaka, Takuji
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 163 - 169
  • [50] Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
    Kentaro Sudo
    Takeshi Ishihara
    Nobuto Hirata
    Fumiaki Ozawa
    Tadashi Ohshima
    Ryosaku Azemoto
    Kenji Shimura
    Takeshi Nihei
    Takayoshi Nishino
    Akihiko Nakagawa
    Kazuyoshi Nakamura
    Taro Hara
    Motohisa Tada
    Rintaro Mikata
    Katsunobu Tawada
    Osamu Yokosuka
    So Nakaji
    Taketo Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 389 - 396
12345